CDKN1A and neoplasm: ANXA7 upregulation may thus chemo-sensitize the tumor if p21 modulators are added to the treatment regimen, as they will counteract the c-MYC overexpression and oncogenic drive towards stemness, which has the same effect as c-MYC inhibition in these conditions.